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OverviewTarget Identification
in Chemical Genetics:
The (Often) Missing Link
out such experiments, particularly biochemical assays,
which are underappreciated but can have a significant
impact on the success or failure of a protein “fishing
expedition.” It is our hope that some of the points raised
here will stimulate and aid new research into this impor-
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Biochemical Approaches to Protein Target ID:Chemists and biologists have been using bioactive small
Some Success Storiesmolecules to manipulate biological pathways for a long
One of the best examples of the power of small mole-time. Until quite recently, by far the most common
cules (in this case a natural product) as discovery toolssource of molecules with potent bioactivity was nature.
in biology is the trapoxin/histone deacetylases story [6,Things are changing, though. While natural products
7]. This work, carried out by Schreiber and colleagues,are, and will remain, an important source of drug leads
was a key contribution to our current understanding ofand research tools, chemical genetics [1–3] is increas-
the critical role of histone deacetylases in repression ofingly being employed to identify compounds with inter-
gene transcription. At the time, it was known that tra-esting activities from compound collections or com-
poxin (Figure 1) inhibited histone deacetylation andbinatorial libraries. This is usually done by arraying
caused phenotypic changes in cells, for example cellcompounds (typically a few hundred to a few thousand)
cycle arrest. But it was not understood why this arrestin the wells of microtiter plates [4] along with cells or
occurred or how it was connected to histone deacetyla-organisms engineered to report a desired phenotype that
tion. In an effort to probe this issue, Taunton et al. [7]might be evoked by the molecule. For example, if the
synthesized an analog of the natural product, calleddesired outcome is to turn on the expression of a particular
K-trap, that facilitated the construction of an affinitygene or set of genes, the cells might be equipped with a
matrix comprised of the small molecule linked covalentlyreporter construct in which the relevant promoter drives
to a resin (Figure 1). Passage of a mammalian cell extractexpression of green fluorescent protein or some other
over this column, followed by thorough washing, re-convenient marker. Alternatively, one can use native
sulted in the enrichment of two major proteins, as visual-cells if the desired phenotype can be detected using
ized by denaturing polyacrylamide gel electrophoresisan antibody, such as the appearance of a cell surface
and silver staining. Subsequent analysis revealed oneprotein modification [5]. In whole organism screens,
of these proteins to be related to a yeast protein calledsuch as abnormal organ formation in a zebrafish, screens
Rpd3 [6], which was known to be involved in the repres-can simply be assessed visually. Chemical genetics
sion of several genes in yeast, but was not known to beassays of this type are useful in providing molecules that
a histone deacetylase (HDAC). Thus, the identificationcan be used to probe the relevant biological pathways
of one of the trapoxin targets (we now know that therein the same way that mutations can be employed in
are at least nine human HDACs) provided a critical miss-genetically malleable model organisms such as yeast.
ing link that brought together many disparate observa-Despite its huge potential, chemical genetics is cur-
tions into a coherent picture. An important point here isrently limited by (at least) two major technical hurdles.
the fact that K-trap and trapoxin dissociate from targetOne is that compounds isolated from such screens are
HDACs only under denaturing conditions. This frus-not terribly potent. Ideally, one would like to have mole-
trated attempts to identify radiolabeled bands on a de-cules that evince their effect at low nM concentrations,
naturing gel when radiolabeled trapoxin was incubatedsince this connotes high affinity and specificity. This is
with extract, but did allow for stringent washing in thealmost never the case, and a low M hit in such screens
affinity experiment to remove all nonspecific bindersis generally considered to be a good result. The rapid
prior to eluting the HDAC from the column [7]. As willmaturation of these hits into more potent reagents without
be elaborated below, the ability to wash such columnsresorting to tedious medicinal chemistry is a major issue
thoroughly is a critical issue in the success of suchin developing a synthetic molecule whose utility as a phar-
experiments.macological reagent rivals that of natural products.
A good example of successful target ID in the caseThe second issue is to identify the target(s) of the
of a library-derived compound is the recent work of Dingbioactive molecule. The reviews presented in this issue
et al. [8]. They screened a library of purine-like moleculesof Chemistry & Biology cover a number of different ap-
for compounds that would induce P19 stem cells toproaches to the target identification (ID) problem in de-
adopt a neuronal fate. One of the molecules that cametail. This overview is meant to complement these more
out of this phenotypic screen was coupled to an affinitydetailed reviews and to provide a global perspective on
matrix and used to probe a P19 cell extract. A moleculeefforts to solve this problem. In addition, we also focus
that did not score as a positive in this assay was alsoon some important technical issues involved in carrying
coupled to a column and employed as a control. Two
bands were highly enriched from the lysate. These were
shown to be forms of GSK-3, a protein kinase known*Correspondence: thomas.kodadek@utsouthwestern.edu
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Figure 1. Natural Product Target Identifica-
tion
(A) Chemical structure of trapoxin.
(B) Chemical structure of the K-trap affinity
matrix.
(C) Silver-stained gel showing human tra-
poxin binding proteins, p55HDAC 1, p50
RbAp48. Proteins bound to the K-trap affinity
matrix in the presence or absence of soluble
trapoxin were eluted by boiling in SDS loading
buffer and analyzed by SDS-PAGE (9% gel).
This panel is reprinted with permission from [6].
to be involved in important developmental pathways, complexes is a key determinant of the success or failure
of an affinity chromatography experiment, since this de-including Wnt signaling [9]. A surface plasmon reso-
nance experiment revealed that the KD of the TWS termines how thoroughly one can wash the resin without
losing all of the bound proteins. Recall that in the tra-119•GSK-3 complex was 126 nM [8], a better than
usual result for a hit from a combinatorial library. This poxin work discussed above, the small molecule-HDAC
complexes dissociated only under denaturing condi-is presumably the result of using a biased library based
on the purine scaffold, which is rich in molecules dis- tions, a highly favorable scenario. The AS-119-GSK-3
complex has a KD in the 100 nM range, at least 10-foldposed to bind protein kinases and other ATP binding
proteins. The relatively high affinity undoubtedly was better than most complexes that result from phenotypic
screens of unbiased libraries.important in the success of this experiment (vide infra).
Thus, GSK-3 is a strong candidate for the physiologi- Another obvious contributor to the success of an affin-
ity binding experiment is the abundance of the targetcally relevant target of the small molecule.
protein(s). This is because an abundant protein need
not be enriched greatly in order to become the mostThe Limitations of Classical Binding Experiments
prominent band on a stained gel. It is far more difficultThe work described above shows clearly that affinity
for a low abundance protein, such as a transcriptionchromatography can be a powerful method for target
factor, to be detected above background in this wayidentification. So why is this journal devoting so much
unless an enormous enrichment is achieved.space to this problem if it can be addressed in such a
These statements may seem obvious now, but thisstraightforward manner? Unfortunately, the truth is that
was not always the case. In the early days of chemicalthis approach often doesn’t work, and almost all suc-
biology, there was a naive assumption that the targetcessful affinity chromatography experiments have in-
ID problem would not be so difficult. In a way, the earlyvolved the happy combination of a high-affinity small
chemical biology community was a victim of its ownmolecule with a fairly abundant protein receptor.
success, since this pathway for target ID worked beauti-It is much easier to characterize high-affinity small
fully in some early experiments. Perhaps the best exam-molecule-protein complexes than those with modest
ple was the identification of FKBP as the target of theaffinity biochemically. Most bioactive synthetic mole-
immunosuppressant FK-506, an effort in which affinitycules are somewhat hydrophobic, and in an aqueous
chromatography played a key role [10]. FKBP is an ex-buffer this “stickiness” will always result in the retention
tremely abundant, highly soluble protein, and the FK-of many proteins from an extract in addition to the physi-
506-FKBP complex has a KD in the low nM range. Whileological relevant target(s). This is particularly true in an
not taking anything away from the brilliance of this pion-affinity chromatography experiment, where an extract
eering work, in retrospect it is clear that one could hardlyis passed over a packed column consisting of the small
have hoped for a more favorable case. It was both luckymolecule immobilized on agarose or some other suitable
and unlucky that the stars aligned so nicely in this earlysupport. In this case, the proteins “see” a high local
work. The good news is that it allowed this fabulousconcentration of the small molecule that is sufficient
story to be unraveled at a rapid pace. The impact of thisto retain both specific and many nonspecific binding
work extended beyond understanding the mechanismpartners. Washing is inevitably required. A high-affinity
of action of the drug in suppressing the immune systemsmall molecule-protein interaction will usually have a
[11]. These experiments had a lot to do with convincingkinetic half-life sufficient to survive extensive washing,
biologists that there really might be something to thewhereas low affinity complexes often will not. This differ-
ential between the lifetimes of nonspecific and specific idea of using chemistry as a key tool in molecular biol-
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ogy, while also suggesting to a recalcitrant synthetic to the latter extreme than the former, with the predict-
able result that a lot of “junk” is retained by the immobi-chemistry community that it might be OK to work with
real biological systems. The bad news is that it created lized molecule (and/or the support itself). This is true
not only for experiments using small molecules as bait.the false impression among chemists without much
classical biochemical experience that the target identifi- Often protein-protein interactions are monitored using
a similar protocol, in which the bait protein is immobi-cation problem could be solved in most cases using
this simple affinity chromatography approach. This view lized on a resin (often in the form of a GST fusion protein
bound to glutathione-agarose) and exposed to an ex-soon crashed upon the rocks of reality. Indeed, some
natural products chemists interested in target ID have tract. Rarely is a large excess of total protein used in
these experiments. These are particularly bad experi-focused entirely on molecules with reactive functional
groups such as epoxides, the expectation being that ments because Western blotting is usually used to probe
for the presence of a suspected binding partner in com-these molecules will form covalent complexes with their
protein targets so that extremely stringent washing con- parison to a control sample displaying the background
proteins retained by GST alone. Rarely is the total re-ditions (including denaturing buffers) can be employed
in biochemical fishing experiments. If the target ID prob- tained protein visualized using stained gels to see
whether or not the band visualized by Western blottinglem is tough for natural products chemists, it is much
worse for chemical geneticists, since, as stated above, is one of a host of bound factors. These inherently biased
experiments have polluted the literature in many areasthey are usually working with far less potent compounds.
of biology. Many of the interactions identified in this way
may be physiologically relevant, but it is hard to tell
The Next Generation of Biochemical Solutions unless there are corroborating data for the interaction,
to the Target ID Problem such as genetic interactions, etc.
Having said this, we are optimistic about the future of There is a reason that this type of experiment is usually
biochemical approaches to the target ID problem in done under suboptimal conditions. If one is interested in
chemical genetics. It seems reasonable to suggest that mammalian cells, it is tedious and expensive to produce
the implementation of several new protocols and tech- large amounts of cell extract. In theory, this would be
niques combined with some clearer analysis of the prob- fine if the amount of bait were reduced, but a certain
lem (vide infra) will have a rejuvenating effect on the minimal level is needed in order to isolate detectable
field. levels of protein binding partners. A simple solution that
First and foremost, as stated above, it would be desir- is often used in our laboratory is to mix the mammalian
able to carry out such “fishing expeditions” with potent, cell extract of interest with a large excess of concen-
and therefore presumably high-affinity, molecules. trated extract obtained from Escherichia coli cells [20].
There have been many reports in the last few years of It is simple and cheap to produce large amounts of
clever strategies to mature modest potency leads into bacterial extract, and this highly heterogeneous mixture
much more potent derivatives without resorting to clas- of proteins does an excellent job of soaking up nonspe-
sical and tedious medicinal chemistry approaches (for cific binding sites, thus competing away nonspecific
a review, see [12]). Many of these approaches involve eukaryotic proteins that might bind and confuse the
creating bivalent protein ligands in which two or more issue. This approach is especially effective if one can
modest affinity, noncompetitive binding elements are label the bacterial and/or the mammalian proteins in
linked in such a way as to provide a high-affinity mole- such a way that they can be easily distinguished. For
cule [13–19] (M. Reddy, K. Bachhawatt-Sikder, and T.K., electrophoretic analysis, one can grow the mammalian
submitted). Most of this work has been done in the cells in the presence of [35S]methionine, but not label
context of simple protein binding or enzyme inhibitor the bacterial proteins, which will then be invisible in an
screens, but there is no reason that the same strategies autoradiogram.
could not be adapted to chemical genetics screens. Another approach to distinguishing nonspecific bind-
Thus, we anticipate that much more potent compounds ers from true target candidates is to compare the pro-
will begin to come out of chemical genetics screens in teins retained by the bioactive molecule of interest and
the near future, making the subsequent target ID prob- those retained by a structurally similar but inactive mole-
lem more tractable. cule (for example, see Figure 2). Ideally, the control mol-
Even with more effective “bait” in hand, another im- ecule would be the enantiomer of the bioactive species
portant improvement will be better experimental design. if the enantiomer were inactive. If this is not the case
An underappreciated detail that has a tremendous im- or if the molecule is achiral, then the closer the control
pact on the level of nonspecific interactions is the molar resembles the “hit,” the better. In such experiments,
ratio of the bait molecule to the protein input. Ideally, mass spectrometry is the preferred method of analysis.
one would like to have a huge excess of input protein One can label the proteins from one sample with a heavy
relative to the bait molecule. Under these conditions, reagent and the proteins from the other with a light
potential binding proteins must compete for limiting bait, reagent (see Figure 3). This can be done at the protein
and only the highest-affinity interactions would be level by growing the cells in labeled media [21] or by
picked up. At the other end of the spectrum, if the bait labeling specific side chains (such as cysteinyl sulfurs)
is used in excess, then any protein with enough affinity [22]. The proteins retained by the hit and by the con-
to survive the washing steps employed will be detected trol compound can then be compared by mixing the two
as a potential binding partner. Unfortunately, most ex- samples prior to analysis, then examining the ratio of
peaks in the mass spectrometer (Figure 3). Pairs of sig-periments of this type are done under conditions closer
Chemistry & Biology
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Figure 2. Target Identification with a Library-
Derived Compound
Portions of this figure were reprinted with per-
mission from [8].
(A) Chemical structure of AS-119, the linker
derivative of TWS-119, a compound selected
from a purine-like library for its ability to in-
duce neuronal differentiation in P19 stem
cells.
(B) Chemical structure of AS-113, the linker
derivative of TWS-113, an inactive library
member.
(C) Silver-stained gel showing proteins re-
tained by AS-119.
(D) Proteins retained by AS-119 were shown
to be GSK-3 by Western blotting.
nals whose ratio is tipped in favor of the retentate of sic concepts apply to any biochemical assay. As re-
viewed by Prestwich in this issue, a promising alternativethe bioactive molecule are candidate target proteins,
since they were retained selectively. This comparative to these methods is to employ chemical crosslinking.
Crosslinking experiments do not require the agent ofmethod provides better sensitivity and higher through-
put than gel-based methods. interest to be immobilized. Thus, it is easier to control
important experimental parameters such as the concen-While the above approach has focused on affinity
chromatography or pulldown-type assays, the same ba- tration of the small molecule probe. We believe that
chemical crosslinking has a very bright future in protein
target identification. However, in order to realize the
full power of this approach, more effective crosslinking
chemistries would be very helpful. In particular, a system
that could be used efficiently inside living cells would
be a tremendous breakthrough. As crosslinking ap-
proaches mature, it would be a good idea to incorporate
the crosslinkable moieties into the core structure of the
molecules that one screens. This would eliminate the
possibility that appending a crosslinkable (or any other)
tag to a given molecule will compromise its activity.
Genetic Approaches to Target Identification
It is a truism that it is easier to work with DNA than
proteins. Therefore, most molecular biologists would
argue that if one can solve a problem using genetics or
some clever molecular biology trick, then this is prefera-
ble to spending several days in the cold room doing
chromatography. Molecular biology approaches are es-
pecially powerful in genetically manipulable organisms,
such as the yeast Saccharomyces cerevisiae. As is laid
out in the review by Zheng et al. in this issue, some of
the most impressive advances in the target ID area have
come through the application of clever cell- and genetic-
based screens. These include three-hybrid systems [23],Figure 3. Isotopic Detection of Enriched Protein Targets
looking for increased drug sensitivity in heterozygote
(A) SILAC, stable isotope labeling with amino acids in cell culture,
collections [24, 25], and a host of other schemes. Whata technique pioneered by Mann and coworkers to quantify protein
makes genetic and cellular approaches so attractive isabundance data. A 12C or 13C amino acid, e.g., 13C-labeled arginine
(6), is supplied to cells in culture [21, 26]. that these provide a tight connection between pheno-
(B) ICAT, isotope coded affinity tagging. Aebersold and others have type and genotype. In other words, a hit in any of these
developed chemical methods for incorporating isotope tags on ame- assays provides the cloned gene for the target protein
nable protein side chains, e.g., cysteine, after protein complexes directly. This is not the case in biochemical assays. On
are eluted from affinity matrices [27].
the other hand, some of these genetic assays require(C) After sample mixing and trypsin digestion, specific protein tar-
that target protein candidates be employed as artificialgets exhibit a Heavy:Light ratio much greater than 1 in the mass
spectrum in contrast to nonspecific interactors [28]. fusion constructs that may or may not behave as the
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